Developer docs
API playgroundTry for free, no card

Search company profiles

H2 Global Group

Full company profile

uuid0005ly1

Namestring
H2 Global Group
Legal namestring
H2 Global Group s.r.o.
Websiteurl
h2global.group
Company typeenum
Private
Founded yearint
2011
Descriptiontext

H2 Global Group is a Czech-based MedTech/HealthTech holding company founded in 2011 by David Maršálek, focused on molecular hydrogen-based technologies for medical, wellness, and longevity applications. The company's core technology centers on molecular hydrogen delivery through multiple modalities, including inhalation generators, hydrogen-enriched water systems, and veterinary devices. Its product portfolio spans regulated medical hardware (VR Vitalis Pro for rehabilitation, H2 Brain Simulation Software, clinical-grade inhalation devices for Alzheimer's therapy), dietary supplements (H2 Brain, H2 Forte, H2 Dent Care), hydrogen-infused cosmetics (H2 InFuse), and consumer products (H2 Bike hydrogen e-bike, H2 Vibe D2C platform).

The company operates a hybrid B2B and D2C business model. On the B2B side, it serves hospitals, rehabilitation institutes, spas, wellness centers, and distributors — anchored by 50+ healthcare partnerships including FN Ostrava, Rehabilitační ústav Hrabyně, Nemocnice AGEL, and Lázně Darkov in the Czech Republic, plus multiple international distributors. On the D2C side, it sells hardware and supplements through the H2 Vibe e-commerce platform to 20,000+ end-customers. Revenue is generated primarily through hardware sales, with one-time licensing for supplements and recurring clinical/enterprise contracts.

H2 Global Group is pursuing an aggressive international and regulatory expansion strategy, anchored by the EP 3701956 patent for hydrogen-based dementia treatment, EU MDR certification, SÚKL-approved clinical study for Alzheimer's (the first of its kind in Europe), veterinary device registration, and FDA certification preparations for the US market. Strategic partnerships with Professor Shigeo Ohta's Japanese research team and Professor David Školoudík provide scientific credibility. Recent expansion includes an India manufacturing/marketing agreement with H2 GenRack (April 2026), product launches across hydrogen supplements, hydrogen e-bikes, and longevity centers, and a planned $25-30M Series A round to fund global scaling.

Short descriptiontext

H2 Global Group is a Czech-based MedTech/HealthTech holding company developing molecular hydrogen medical devices, dietary supplements, and consumer health products. It serves hospitals, rehabilitation institutes, wellness centers, and D2C consumers across European and emerging markets.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersOstrava, Czechia
HQ citystring
Ostrava
HQ countrystring
Czechia
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
molecular hydrogen technology, medical hydrogen devices, hydrogen inhalation therapy, therapeutic dietary supplements, VR rehabilitation systems
Industry5 codes
PRIMARYHLAHAGAD
Oxygen Therapy Systems (Concentrators, Cylinders, Liquid O2, HFNC)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Respiratory & Sleep Therapy Devices
SECONDARYHLAKANAM
Home Ventilation, Oxygen Therapy & Respiratory DME Clinical Management
SECONDARYHSADAKAK
Oxygen Therapy Bars (O2)
SECONDARYMPAFAGAG
VR/XR Hardware & Accessories (Headsets, Controllers, Trackers, Haptics)
Media, Entertainment & Sports/Gaming & Interactive Entertainment (Video Games, Esports)/Gaming Hardware & Peripherals (Consoles, PCs, Controllers, VR)
SECONDARYHLAHAGAK
Anesthesia & Respiratory Gas Delivery Equipment (Breathing Circuits, Vaporizers, Gas Mixers)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Respiratory & Sleep Therapy Devices
NAICS code1 code
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code2 codes
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
  • Biological Products, (No Disgnostic Substances)2836
Product category
Molecular Hydrogen Medical Devices
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model4 records
1Hydrogen Water and Generator Sales
TypeHardware Sales
Description

Sale of molecular hydrogen water devices and hydrogen generators to healthcare facilities and consumers

2Dietary Supplements
TypeOne Time License
Description

Sale of H2 Brain and other hydrogen-based dietary supplements through B2B and D2C channels

3Medical Device Sales
TypeHardware Sales
Description

Sale of medical-grade hydrogen inhalation devices and therapeutic equipment to healthcare institutions

4B2B Partnerships and Distribution
TypeHardware Sales
Description

Revenue from distributor agreements and B2B partnerships with medical facilities, spas, and wellness centers

Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Supply Chain, Operations, Personnel, Marketing or Sales, Infrastructure
GTM typeB2B and B2C
B2B and B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 12 records shown
1H2 Vibe
Description

Consumer-focused molecular hydrogen products including dietary supplements, hydrogen water, and generators for individual use

h2global.group
+11 more records
Core offering1 text field

H2 Global Group develops, manufactures, and distributes molecular hydrogen-based medical devices, therapeutic equipment, dietary supplements, hydrogen-enriched water, cosmetics, and hydrogen-powered mobility products. The company sells its hydrogen generators, inhalation devices, and VR rehabilitation systems to healthcare facilities, spas, sports clubs, and veterinary clinics (B2B), while also running the H2 Vibe consumer e-commerce storefront for individual wellness customers (B2C). It holds an equity stake in VR LIFE, whose MDR-certified VR Vitalis Pro medical device is deployed in 40+ European hospitals.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 20,000+ end-customers served
+2 more records
Product overview1 text field

H2 Global Group operates as a vertically integrated MedTech ecosystem centered on molecular hydrogen applications. The portfolio combines regulated medical devices (H2 Medical Technologies hydrogen inhalation device for Alzheimer's clinical trials, VR Vitalis Pro VR rehabilitation system), B2B therapeutic solutions (hydrogen generators for healthcare/wellness/veterinary use), and consumer products (H2 Vibe brand including H2 Premium Water, H2 Brain dietary supplement, H2 InFuse cosmetics). The company also holds investments in VR LIFE portfolio company and develops technology platforms for longevity, mobility, energy, and agriculture applications.

Product and service10 records
1H2 Medical Technologies Hydrogen Inhalation Device
CategoryMedical Device
Description

Medical device prototype for controlled hydrogen inhalation therapy, designed for clinical trials targeting Alzheimer's disease prevention and treatment. Generates molecular hydrogen at safe, low concentrations for patient use.

2VR Vitalis Pro
CategoryMedical Device / Rehabilitation Software
Description

MDR-certified medical device for rehabilitation and neurorehabilitation using virtual reality. Hospital SaaS system with 52+ therapeutic modules covering upper/lower limb exercises, back and neck, respiratory exercises, cognitive training, fine motor skills, and relaxation. Supports hand tracking for patients with cognitive deficit or limited motor skills; deployed in 40+ healthcare facilities.

3H2 Premium Water
CategoryConsumer Wellness Product
Description

Hydrogen-enriched drinking water with high dissolved molecular hydrogen concentration, supporting hydration, antioxidant benefits, and overall wellness for individual consumers.

4H2 Brain Dietary Supplement
CategoryDietary Supplement
Description

Two-phase dietary supplement with HydrogenIQ complex that stimulates molecular hydrogen production through gut microbiome. Morning tablet (skullcap extract, astaxanthin, selenium) supports mental performance and concentration; evening tablet (taurin, B vitamins, ginkgo biloba) supports mental relaxation and quality sleep.

5H2 InFuse Cosmetic Line
CategoryCosmetics
Description

Cosmetic line featuring patent-pending technology that generates molecular hydrogen directly on skin through body wraps, regular skincare, or hydrogen baths via dissolving tablets. Provides anti-aging, skin brightening, hydration, and lifting effects.

6Veterinary Hydrogen Generators
CategoryVeterinary Medical Device
Description

Molecular hydrogen generators officially recognized and listed as veterinary technical devices (VTP/004/24-C) by the Institute for State Control of Veterinary Biopreparations and Medicines in Brno. Used for animal health, vitality promotion, and regeneration acceleration in veterinary clinics and breeding facilities.

7Medical-Grade Hydrogen Generators (Inhalation)
CategoryMedical Device
Description

Medical-grade hydrogen generators for inhalation therapy, used in healthcare facilities, wellness centers, and for clinical research purposes. Supports anti-inflammatory, antioxidant, and regenerative effects.

8H2 Bike Hydrogen E-Bike
CategoryMobility Product
Description

Hydrogen-powered electric bike, the first hydrogen e-bike developed in Czech Republic. Features 60+ km range, minutes refueling time, lightweight design, high efficiency, independent of grid infrastructure. Designed for urban mobility and shared city mobility schemes.

9H2 Dent Care
CategoryDietary Supplement
Description

Dietary supplement for oral health support using molecular hydrogen. Contains antioxidant and anti-inflammatory properties to reduce oxidative stress in the mouth and support gum regeneration. Complements treatment of gum disease.

10H2 Brain Simulation Software
CategoryResearch Software
Description

Proprietary brain simulation software that models complex interactions in the human brain affected by Alzheimer's pathology. Analyzes oxidative stress, mitochondrial dysfunction, and neuroinflammation to understand cognitive decline factors. Used for research and therapy development.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership7 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Strategic partnership for virtual reality rehabilitation technology combining immersive VR therapy with hydrogen treatment protocols for enhanced patient outcomes

2Professor Shigeo Ohta
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Scientific co-founder and key patent holder in molecular hydrogen therapy research, providing scientific credibility and intellectual property portfolio

3Meda LT
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

National distributor for Lithuania covering all product lines including hydrogen water generators and medical devices

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Distributor for Slovenia handling product distribution and local market penetration

5H2 Antioxidant
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Distributor for Spain covering Spanish market distribution of hydrogen wellness products

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Regional distributor handling product distribution across designated territories

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Partner organization for product distribution and market development

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Direct-to-consumer hydrogen water and tablet products targeting health-conscious consumers; directly comparable to H2 Vibe's H2 Premium Water and H2 Brain supplement lines in product format, mechanism (dissolved molecular hydrogen), and consumer wellness positioning.

2XRHealth
TypeDirect peer
Description

Operates VR-based tele-rehabilitation clinics for neurological and orthopedic conditions on a SaaS basis; comparable to VR Vitalis Pro's 52+ therapeutic modules and hospital SaaS delivery model targeting rehabilitation centers.

TypeBroad incumbent
Description

Public medical device company with FDA-cleared REAL VR rehabilitation system used in US hospitals; serves as a scaled incumbent reference for VR Vitalis Pro's regulatory and commercial pathway into US acute and outpatient rehab.

TypeBroad incumbent
Description

Global industrial and medical gas major supplying oxygen, hydrogen, and respiratory therapy gases to hospitals and homecare; a potential strategic acquirer or distributor comparable to H2 Global's medical-grade hydrogen inhalation business and a benchmark for medical gas regulation and reimbursement.

TypeEmerging player
Description

Developer of non-invasive brain stimulation devices used in clinical research and treatment of neurological conditions; comparable to H2 Medical Technologies' non-invasive therapeutic approach for Alzheimer's and cognitive decline as well as its clinical study positioning.

TypeDirect peer
Description

Developer of MDR/FDA-cleared VR-based neurological rehabilitation and assessment platforms deployed across hospitals; directly comparable to VR Vitalis Pro, which H2 Global is positioning as part of its integrated MedTech portfolio with US market entry plans.

7Tracie McGrane / H2 Wellness Group (molecular hydrogen therapy clinics)
TypeDirect peer
Description

Operating wellness clinics that offer molecular hydrogen inhalation and hydrogen-rich water therapy; directly comparable to H2 Global's H2 Longevity Ostrava center and B2B spa/rehabilitation channel offering hydrogen inhalation protocols.

8Molecular Hydrogen Institute
TypeOthers
Description

Independent research and education body curating clinical studies on molecular hydrogen therapy; functions as a knowledge ecosystem for the same scientific literature H2 Global cites, and is a relevant comparator for credibility, indication prioritization, and scientific advisory engagement.

TypeEmerging player
Description

Specialty diagnostics and personalized medicine company developing biomarker-based tools for neurological conditions including Alzheimer's; comparable to H2 Medical Technologies' clinical biomarker work and H2 Brain simulation software modeling oxidative stress and neuroinflammation in Alzheimer's pathology.

TypeBroad incumbent
Description

Medical gas and home respiratory therapy provider across Europe; relevant incumbent for H2 Global's home/hospital hydrogen inhalation ambitions and a likely candidate as strategic partner or acquirer given the company's explicit $500M-$1.5B exit target.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers11 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment7 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries6 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment1 record

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

H2 Global Group

Molecular Hydrogen Medical Devicesh2global.group

H2 Global Group is a Czech-based MedTech/HealthTech holding company developing molecular hydrogen medical devices, dietary supplements, and consumer health products. It serves hospitals, rehabilitation institutes, wellness centers, and D2C consumers across European and emerging markets.

What H2 Global Group does

H2 Global Group is a Czech-based MedTech/HealthTech holding company founded in 2011 by David Maršálek, focused on molecular hydrogen-based technologies for medical, wellness, and longevity applications. The company's core technology centers on molecular hydrogen delivery through multiple modalities, including inhalation generators, hydrogen-enriched water systems, and veterinary devices. Its product portfolio spans regulated medical hardware (VR Vitalis Pro for rehabilitation, H2 Brain Simulation Software, clinical-grade inhalation devices for Alzheimer's therapy), dietary supplements (H2 Brain, H2 Forte, H2 Dent Care), hydrogen-infused cosmetics (H2 InFuse), and consumer products (H2 Bike hydrogen e-bike, H2 Vibe D2C platform).

The company operates a hybrid B2B and D2C business model. On the B2B side, it serves hospitals, rehabilitation institutes, spas, wellness centers, and distributors — anchored by 50+ healthcare partnerships including FN Ostrava, Rehabilitační ústav Hrabyně, Nemocnice AGEL, and Lázně Darkov in the Czech Republic, plus multiple international distributors. On the D2C side, it sells hardware and supplements through the H2 Vibe e-commerce platform to 20,000+ end-customers. Revenue is generated primarily through hardware sales, with one-time licensing for supplements and recurring clinical/enterprise contracts.

H2 Global Group is pursuing an aggressive international and regulatory expansion strategy, anchored by the EP 3701956 patent for hydrogen-based dementia treatment, EU MDR certification, SÚKL-approved clinical study for Alzheimer's (the first of its kind in Europe), veterinary device registration, and FDA certification preparations for the US market. Strategic partnerships with Professor Shigeo Ohta's Japanese research team and Professor David Školoudík provide scientific credibility. Recent expansion includes an India manufacturing/marketing agreement with H2 GenRack (April 2026), product launches across hydrogen supplements, hydrogen e-bikes, and longevity centers, and a planned $25-30M Series A round to fund global scaling.

H2 Global Group firmographics

Firmographics
Name
H2 Global Group
Legal name
H2 Global Group s.r.o.
Website
https://h2global.group
Company type
Private
Founded year
2011
Operating status
Operating
Headcount range
1–10 employees
Short description
H2 Global Group is a Czech-based MedTech/HealthTech holding company developing molecular hydrogen medical devices, dietary supplements, and consumer health products. It serves hospitals, rehabilitation institutes, wellness centers, and D2C consumers across European and emerging markets.
Ownership category
akta.pro rank

H2 Global Group industry classification

Industry
Product category
Molecular Hydrogen Medical Devices
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Biological Products, (No Disgnostic Substances) (2836)
akta.pro industry
PRIMARYHLAHAGAD
Oxygen Therapy Systems (Concentrators, Cylinders, Liquid O2, HFNC)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Respiratory & Sleep Therapy Devices
SECONDARYHLAKANAM
Home Ventilation, Oxygen Therapy & Respiratory DME Clinical Management
SECONDARYHSADAKAK
Oxygen Therapy Bars (O2)
SECONDARYMPAFAGAG
VR/XR Hardware & Accessories (Headsets, Controllers, Trackers, Haptics)
Media, Entertainment & Sports/Gaming & Interactive Entertainment (Video Games, Esports)/Gaming Hardware & Peripherals (Consoles, PCs, Controllers, VR)
SECONDARYHLAHAGAK
Anesthesia & Respiratory Gas Delivery Equipment (Breathing Circuits, Vaporizers, Gas Mixers)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Respiratory & Sleep Therapy Devices

Keywords

  • Molecular hydrogen technology
  • Medical hydrogen devices
  • Hydrogen inhalation therapy
  • Therapeutic dietary supplements
  • VR rehabilitation systems

Where H2 Global Group is headquartered

Location

Headquarters

HQ city
Ostrava
HQ country
Czechia
HQ region
Europe

Offices1 record

Markets served

H2 Global Group business model

Business model
GTM type
B2B and B2C
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Supply Chain, Operations, Personnel, Marketing or Sales, Infrastructure

Revenue model

  1. Hydrogen Water and Generator Sales: Sale of molecular hydrogen water devices and hydrogen generators to healthcare facilities and consumers
  2. Dietary Supplements: Sale of H2 Brain and other hydrogen-based dietary supplements through B2B and D2C channels
  3. Medical Device Sales: Sale of medical-grade hydrogen inhalation devices and therapeutic equipment to healthcare institutions
  4. B2B Partnerships and Distribution: Revenue from distributor agreements and B2B partnerships with medical facilities, spas, and wellness centers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels4 records

H2 Global Group product offering

Product offering

Core offering

H2 Global Group develops, manufactures, and distributes molecular hydrogen-based medical devices, therapeutic equipment, dietary supplements, hydrogen-enriched water, cosmetics, and hydrogen-powered mobility products. The company sells its hydrogen generators, inhalation devices, and VR rehabilitation systems to healthcare facilities, spas, sports clubs, and veterinary clinics (B2B), while also running the H2 Vibe consumer e-commerce storefront for individual wellness customers (B2C). It holds an equity stake in VR LIFE, whose MDR-certified VR Vitalis Pro medical device is deployed in 40+ European hospitals.

Product overview

H2 Global Group operates as a vertically integrated MedTech ecosystem centered on molecular hydrogen applications. The portfolio combines regulated medical devices (H2 Medical Technologies hydrogen inhalation device for Alzheimer's clinical trials, VR Vitalis Pro VR rehabilitation system), B2B therapeutic solutions (hydrogen generators for healthcare/wellness/veterinary use), and consumer products (H2 Vibe brand including H2 Premium Water, H2 Brain dietary supplement, H2 InFuse cosmetics). The company also holds investments in VR LIFE portfolio company and develops technology platforms for longevity, mobility, energy, and agriculture applications.

Differentiator

Problem solved

Functional benefit

Brands

  • H2 Vibe: Consumer-focused molecular hydrogen products including dietary supplements, hydrogen water, and generators for individual use
  • H2 Medical Technologies
  • H2 Pharm
  • H2 Premium Water
  • H2 Brain
  • H2 Forte
  • H2 Dent Care
  • H2 InFuse
  • VR Vitalis
  • H2 Longevity
  • H2 Bike
  • H2 Investment

Products and services

  • H2 Medical Technologies Hydrogen Inhalation Device Medical device prototype for controlled hydrogen inhalation therapy, designed for clinical trials targeting Alzheimer's disease prevention and treatment. Generates molecular hydrogen at safe, low concentrations for patient use.
  • VR Vitalis Pro MDR-certified medical device for rehabilitation and neurorehabilitation using virtual reality. Hospital SaaS system with 52+ therapeutic modules covering upper/lower limb exercises, back and neck, respiratory exercises, cognitive training, fine motor skills, and relaxation. Supports hand tracking for patients with cognitive deficit or limited motor skills; deployed in 40+ healthcare facilities.
  • H2 Premium Water Hydrogen-enriched drinking water with high dissolved molecular hydrogen concentration, supporting hydration, antioxidant benefits, and overall wellness for individual consumers.
  • H2 Brain Dietary Supplement Two-phase dietary supplement with HydrogenIQ complex that stimulates molecular hydrogen production through gut microbiome. Morning tablet (skullcap extract, astaxanthin, selenium) supports mental performance and concentration; evening tablet (taurin, B vitamins, ginkgo biloba) supports mental relaxation and quality sleep.
  • H2 InFuse Cosmetic Line Cosmetic line featuring patent-pending technology that generates molecular hydrogen directly on skin through body wraps, regular skincare, or hydrogen baths via dissolving tablets. Provides anti-aging, skin brightening, hydration, and lifting effects.
  • Veterinary Hydrogen Generators Molecular hydrogen generators officially recognized and listed as veterinary technical devices (VTP/004/24-C) by the Institute for State Control of Veterinary Biopreparations and Medicines in Brno. Used for animal health, vitality promotion, and regeneration acceleration in veterinary clinics and breeding facilities.
  • Medical-Grade Hydrogen Generators (Inhalation) Medical-grade hydrogen generators for inhalation therapy, used in healthcare facilities, wellness centers, and for clinical research purposes. Supports anti-inflammatory, antioxidant, and regenerative effects.
  • H2 Bike Hydrogen E-Bike Hydrogen-powered electric bike, the first hydrogen e-bike developed in Czech Republic. Features 60+ km range, minutes refueling time, lightweight design, high efficiency, independent of grid infrastructure. Designed for urban mobility and shared city mobility schemes.
  • H2 Dent Care Dietary supplement for oral health support using molecular hydrogen. Contains antioxidant and anti-inflammatory properties to reduce oxidative stress in the mouth and support gum regeneration. Complements treatment of gum disease.
  • H2 Brain Simulation Software Proprietary brain simulation software that models complex interactions in the human brain affected by Alzheimer's pathology. Analyzes oxidative stress, mitochondrial dysfunction, and neuroinflammation to understand cognitive decline factors. Used for research and therapy development.

Quantifiable outcome

  • 20,000+ end-customers served
  • +2 more outcomes

Companies that use H2 Global Group

Customer profile

Named customers11 records

Segments7 records

Ideal customer profiles4 records

H2 Global Group technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature4 records

H2 Global Group partnerships and signals

Strategic signal

Partnerships

Seven partnerships are on record, tiered core and minor.

  • VR LIFEcoreStrategic or Co-development PartnerStrategic partnership for virtual reality rehabilitation technology combining immersive VR therapy with hydrogen treatment protocols for enhanced patient outcomes
  • Professor Shigeo OhtacoreStrategic or Co-development PartnerScientific co-founder and key patent holder in molecular hydrogen therapy research, providing scientific credibility and intellectual property portfolio
  • Meda LTminorChannel Partner/ Reseller/ DistributorNational distributor for Lithuania covering all product lines including hydrogen water generators and medical devices
  • AquasanaminorChannel Partner/ Reseller/ DistributorDistributor for Slovenia handling product distribution and local market penetration
  • H2 AntioxidantminorChannel Partner/ Reseller/ DistributorDistributor for Spain covering Spanish market distribution of hydrogen wellness products
  • eNecont s.r.o.minorChannel Partner/ Reseller/ DistributorRegional distributor handling product distribution across designated territories
  • TomtonminorChannel Partner/ Reseller/ DistributorPartner organization for product distribution and market development

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

H2 Global Group competitors and assessment

Company assessment

Direct peers

  • AquaHydrate / Hydrant (hydrogen water tablets): Direct-to-consumer hydrogen water and tablet products targeting health-conscious consumers; directly comparable to H2 Vibe's H2 Premium Water and H2 Brain supplement lines in product format, mechanism (dissolved molecular hydrogen), and consumer wellness positioning.
  • XRHealth: Operates VR-based tele-rehabilitation clinics for neurological and orthopedic conditions on a SaaS basis; comparable to VR Vitalis Pro's 52+ therapeutic modules and hospital SaaS delivery model targeting rehabilitation centers.
  • MindMaze: Developer of MDR/FDA-cleared VR-based neurological rehabilitation and assessment platforms deployed across hospitals; directly comparable to VR Vitalis Pro, which H2 Global is positioning as part of its integrated MedTech portfolio with US market entry plans.
  • Tracie McGrane / H2 Wellness Group (molecular hydrogen therapy clinics): Operating wellness clinics that offer molecular hydrogen inhalation and hydrogen-rich water therapy; directly comparable to H2 Global's H2 Longevity Ostrava center and B2B spa/rehabilitation channel offering hydrogen inhalation protocols.

Broad incumbents

  • Penumbra (REAL Immersive System): Public medical device company with FDA-cleared REAL VR rehabilitation system used in US hospitals; serves as a scaled incumbent reference for VR Vitalis Pro's regulatory and commercial pathway into US acute and outpatient rehab.
  • Linde plc: Global industrial and medical gas major supplying oxygen, hydrogen, and respiratory therapy gases to hospitals and homecare; a potential strategic acquirer or distributor comparable to H2 Global's medical-grade hydrogen inhalation business and a benchmark for medical gas regulation and reimbursement.
  • Air Liquide Healthcare: Medical gas and home respiratory therapy provider across Europe; relevant incumbent for H2 Global's home/hospital hydrogen inhalation ambitions and a likely candidate as strategic partner or acquirer given the company's explicit $500M-$1.5B exit target.

Emerging players

  • Neuroelectrics: Developer of non-invasive brain stimulation devices used in clinical research and treatment of neurological conditions; comparable to H2 Medical Technologies' non-invasive therapeutic approach for Alzheimer's and cognitive decline as well as its clinical study positioning.
  • Saladax Biomedical: Specialty diagnostics and personalized medicine company developing biomarker-based tools for neurological conditions including Alzheimer's; comparable to H2 Medical Technologies' clinical biomarker work and H2 Brain simulation software modeling oxidative stress and neuroinflammation in Alzheimer's pathology.

Others

  • Molecular Hydrogen Institute: Independent research and education body curating clinical studies on molecular hydrogen therapy; functions as a knowledge ecosystem for the same scientific literature H2 Global cites, and is a relevant comparator for credibility, indication prioritization, and scientific advisory engagement.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

H2 Global Group social profiles

Digital presence

H2 Global Group compliance and trust

Trust signal

Compliance4 records

H2 Global Group financial estimates

Financial estimate

Revenue estimate

Valuation estimate

H2 Global Group leadership team

Management profile

Number of profiles

Profiles6 records

H2 Global Group subsidiaries and ownership

Company hierarchy

Subsidiaries6 records

H2 Global Group funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

H2 Global Group M&A and investment

M&A and investment

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about H2 Global Group

What does H2 Global Group do?

H2 Global Group develops, manufactures, and distributes molecular hydrogen-based medical devices, therapeutic equipment, dietary supplements, hydrogen-enriched water, cosmetics, and hydrogen-powered mobility products. The company sells its hydrogen generators, inhalation devices, and VR rehabilitation systems to healthcare facilities, spas, sports clubs, and veterinary clinics (B2B), while also running the H2 Vibe consumer e-commerce storefront for individual wellness customers (B2C). It holds an equity stake in VR LIFE, whose MDR-certified VR Vitalis Pro medical device is deployed in 40+ European hospitals.

Is H2 Global Group a public or private company?

H2 Global Group is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was H2 Global Group founded?

H2 Global Group was founded in 2011. It employs 1 to 10 people.

Where is H2 Global Group based?

H2 Global Group is headquartered in Ostrava, Czechia, in the Europe region.

How does H2 Global Group make money?

Four revenue lines are on record. Hydrogen Water and Generator Sales are the primary driver. The others are dietary Supplements, medical Device Sales and B2B Partnerships and Distribution.

Who are H2 Global Group's main competitors?

Direct peers on record are AquaHydrate / Hydrant (hydrogen water tablets), XRHealth, MindMaze and Tracie McGrane / H2 Wellness Group (molecular hydrogen therapy clinics). Broad incumbents are Penumbra (REAL Immersive System), Linde plc and Air Liquide Healthcare. Emerging players are Neuroelectrics and Saladax Biomedical. Molecular Hydrogen Institute is listed as an others.

Does H2 Global Group have an API?

No public API is recorded for H2 Global Group.

What industry is H2 Global Group in?

H2 Global Group's product category is Molecular Hydrogen Medical Devices. Its primary akta.pro industry code is HLAHAGAD, Oxygen Therapy Systems (Concentrators, Cylinders, Liquid O2, HFNC), with a secondary code of HLAKANAM, Home Ventilation, Oxygen Therapy & Respiratory DME Clinical Management. Its NAICS code is 334510 and its SIC code is 3842.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
EIN PresswireNew Cochrane Review Questions Alzheimer’s Drugs; Czech Company Unveils AlternativeCochrane's April 2026 review of anti-amyloid Alzheimer's drugs found only trivial clinical benefits, citing increased brain swelling and microhemorrhages. H2 Global Group responded by proposing a molecular hydrogen and VR therapy to all 27 EU leaders, with a patent and a clinical study launched in January 2026.EIN PresswireU.S. Military and First Responders in Focus: European MedTech Innovator with Japanese Roots Signals Value to InvestorsH2 Global Group's VR LIFE closed a $650,000 seed round, doubling its stake value to $1.38 million. The company targets a $500M–$1.5B transaction within three years, with U.S. FDA certification underway. It also reports military interest in its molecular hydrogen and VR rehabilitation platform.EIN PresswireStrong Signal for Investors and Partners: H2 Global Group and VR LIFE Validate the Value of European MedTech InnovationH2 Global Group, a Czech Republic-based MedTech company, announced that its portfolio company VR LIFE completed a $650,000 seed round in February 2026, more than doubling the implied value of H2 Global Group's stake from approximately $630,000 to $1.38 million. The group has opened a strategic investment window with an $80 million pre-money valuation, targeting a $500 million to $1.5 billion transaction value within three years through FDA certification in the United States and a planned acquisition by a major global medical technology or pharmaceutical player. H2 Global Group is also advancing clinical studies through its subsidiary H2 Medical Technologies following regulatory approval from the Czech State Institute for Drug Control, with its molecular hydrogen and virtual reality rehabilitation platform deployed across over 40 European healthcare facilities.Business Wire BlogStrong Signal for Investors: VR LIFE and H2 Global Group Validate the Value of European MedTech InnovationH2 Global Group announced that its investment in VR LIFE, following a $650,000 seed round backed by institutional investors, more than doubled in under three years to approximately $1.38 million. VR LIFE, which has an MDR-certified medical device (VR Vitalis Pro) and an established European clinical footprint across more than 40 healthcare facilities, is now preparing for FDA certification to enter the U.S. market. With a current pre-money valuation of approximately $67 million, H2 Global Group is pursuing a strategic objective of achieving a transaction value between $500 million and $1.5 billion within three years through its vertically integrated MedTech ecosystem.MorningstarStrong Signal for Investors: VR LIFE and H2 Global Group Validate the Value of European MedTech InnovationH2 Global Group, a Czech Republic-based European technology group focused on healthcare innovation, announced that its original investment in VR LIFE more than doubled in under three years, reaching approximately $1.38 million following a $650,000 seed round backed by institutional investors. VR LIFE, which holds MDR certification for its VR Vitalis Pro medical device and operates across more than 40 healthcare facilities in Europe, is now preparing for FDA certification to support planned entry into the U.S. market. With a current pre-money valuation of approximately $67 million, H2 Global Group is pursuing a strategic objective of achieving a transaction value between $500 million and $1.5 billion within three years.PR NewswireCzech Innovation Against Alzheimer's: H2 Global Group Enters Key Growth PhaseH2 Global Group, with its subsidiary H2 Medical Technologies, entered a growth phase after presenting a hydrogen therapy device at LSI Europe 2025. The company raised over $18M in seed funding and plans a $25–30M Series A to expand globally and complete clinical trials. Revenue is projected to reach nearly $48M by 2029.PR NewswireCzech MedTech Startup Unveils World's First Patented Hydrogen-Based Therapy with the Potential to Target Alzheimer's DiseaseCzech MedTech company H2 Medical Technologies, part of H2 Global Group, has developed the world's first functional hydrogen-based therapy medical device prototype for clinical trials aimed at preventing and treating Alzheimer's disease. The technology, built on 30+ years of research, is being presented at LSI Europe 2025 in London as the company seeks U.S. and global investment partners, with EU registration underway and FDA approval next on its roadmap. The global Alzheimer's therapeutics market is projected to exceed $20 billion by 2030, and the company positions itself as the only functional hydrogen-based therapy of its kind, targeting the world's largest healthcare market.PR NewswireCzech MedTech Startup H2 Medical Technologies Unveils World's First Patented Hydrogen-Based Therapy with the Potential to Target Alzheimer's DiseaseH2 Medical Technologies, a Czech MedTech startup and part of H2 Global Group, has developed a prototype hydrogen-based therapy medical device for clinical trials targeting both prevention and treatment of Alzheimer's disease, claiming it is the world's first functional device of its kind. The company is seeking U.S. and global investment partners as it pursues EU registration and FDA approval to enter the world's largest healthcare market, with the global Alzheimer's therapeutics market projected to exceed $20 billion by 2030. H2 Global Group will present the breakthrough at LSI Europe 2025 in London, building on 30+ years of research conducted with Professor Shigeo Ohta.